test

Roderick Wong

@Rtw Investments, Lp

Latest period2024 - Q3ReportedManaged Assets$6.911BTotal holdings68
Assets growth rate7%Assets growth rate (2-Q avg)1.18%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Rtw Investments, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.

Assets under management

The assets under management (AUM) of Rtw Investments, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.911B in assets, with a quarterly growth rate of 7% and a 2-quarter average growth rate of 1.18%. The portfolio is managed by Roderick Wong, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MDGLMadrigal Pharmaceuticals Inc
Recent Activity
Increased 4.07%
6.13%
$423.1M
1.994M shares@ $212.22 avg price
DYNDyne Therapeutics Inc
Recent Activity
Increased 6.76%
3.55%
$244.926M
6.819M shares@ $35.93 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
Increased 2.65%
3.54%
$244.175M
5.426M shares@ $45.0 avg price
BRKRBruker Corp
Recent Activity
Increased 1.08%
3.48%
$240.406M
3.481M shares@ $69.06 avg price
AKROAkero Therapeutics Inc
Recent Activity
Increased 8.98%
2.46%
$169.829M
5.919M shares@ $28.69 avg price
PENPenumbra Inc
Recent Activity
Increased 7.23%
2.24%
$154.622M
795,750 shares@ $194.32 avg price
CRGXCargo Therapeutics Inc
Recent Activity
Increased 0.52%
1.1%
$75.626M
4.099M shares@ $18.46 avg price
STOKStoke Therapeutics Inc
Recent Activity
Increased 10.12%
0.83%
$57.177M
4.652M shares@ $12.3 avg price
URGNUrogen Pharma Ltd
Recent Activity
Increased 6.47%
0.7%
$48.099M
3.787M shares@ $12.71 avg price
NGNENeurogene Inc
Recent Activity
Increased 6.05%
0.69%
$47.635M
1.135M shares@ $41.97 avg price